Skip to main content

Table 2 Previous and current diagnostic criteria for neurofibromatosis 2

From: The genetic landscape and possible therapeutics of neurofibromatosis type 2

NIH criteriaa

Manchester criteriaa

2016 consensusa

2019 consensusa

2022 consensusa

1. Bilateral 8th nerve massesb

1. Bilateral VS

1. Bilateral VS aged < 70 years

1. Same as 2016

1. Bilateral VS

2. FDR with NF2, plus

- unilateral 8th nerve mass, or

-two NF-related lesionsc

2. FDR with NF2, plus

- unilateral VS, or

-two NF-related lesionsc

2. FDR with NF2, plus unilateral VS aged < 70 years

2. FDR other than siblings with NF2, plus unilateral VS aged < 70 years

2. Identical NF2 pathogenic variant in ≥ two distinct NF2-related tumorsg, h

3. Unilateral VS, plus

-two NF-related lesionsc

3. FDR with NF2, or unilateral VS, plus two NF-related lesionsd, e

3. FDR other than siblings with NF2, or unilateral VS, plus two NF-related lesionsf, e

3. Two major or one major and two minor criteria, as follows:

4. Multiple meningioma, plus

-unilateral VS, or

-two NF-related lesionsc

4. Multiple meningioma, plus two of unilateral VS or other NF-related lesionsd

4. Multiple meningioma, plus two of unilateral VS or other NF-related lesionsf, e

Major criteria:

-Unilateral VS

-FDR other than siblings with NF2

- ≥ 2 meningiomas

- NF2 pathogenic variant in an unaffected tissue (e.g., blood, saliva)

5. Constitutional pathogenic NF2 gene variant in blood or identical mutations in two distinct tumors

5. Same as 2016

Minor criteria:

- > one NF-related lesion

- Juvenile subcapsular or cortical cataract, retinal hamartoma, epiretinal membrane in a person aged < 40 years

-Specific pattern of genetic changesi

  1. CT scan, computed tomography scan; FDR, first-degree relative; LTZR1, leucine zipper like transcription regulator 1; MRI, magnetic resonance imaging; NF2, neurofibromatosis type 2; NIH; national institute of health; VS, vestibular schwannoma
  2. aThe diagnosis is established if any criteria is met
  3. bBased on CT scan or MRI
  4. cNeurofibroma, meningioma, glioma, schwannoma, and juvenile posterior subcapsular lenticular opacity
  5. dNeurofibroma, meningioma, glioma, schwannoma, cerebral calcification, cataract
  6. eIf unilateral VS and ≥ 2 non-intradermal schwannomas must be LZTR1 negative
  7. fMeningioma, ependymoma, schwannoma, cerebral calcification, cataract
  8. gSchwannoma, meningioma, and/or ependymoma
  9. hIf the variant allele fraction in unaffected tissues such as blood is clearly < 50%, the diagnosis is mosaic NF2
  10. iAccording to ref. no [76]